Brain Pacemaker Global Market Report 2024 - By Growth, Size, Share, Demand, Industry Analysis, Forecast To 2033

"The new report published by The Business Research Company, titled ""Brain Pacemaker Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the brain pacemaker market size has grown rapidly in recent years. It will grow from $1.37 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The brain pacemaker market size is expected to see rapid growth in the next few years. It will grow to $2.77 billion in 2028 at a compound annual growth rate (CAGR) of 15.2%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16634&type=smp

Driving Factors Behind the Growth of the Brain Pacemaker Market Amidst Rising Neurological Illnesses
The growing incidence of neurological illnesses is expected to propel the growth of the brain pacemaker market going forward. Neurological illnesses, also known as neurological disorders, are conditions that affect the nervous system. The growing incidence of neurological illnesses is primarily due to an aging population, lifestyle habits, environmental exposures, genetic predispositions, infectious diseases, traumatic injuries, healthcare disparities, and the effects of urbanization and industrialization. A brain pacemaker helps in neurological illnesses by delivering targeted electrical impulses to regulate abnormal brain activity, alleviating symptoms, and improving the quality of life for patients with neurological conditions. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, over 40% of the global population suffers from some neurological condition, which is projected to nearly double by 2050. Further, the number of people who die from stroke globally is estimated to be 9.7 million deaths per year, which is expected to increase by 50% by 2050. Therefore, the growing incidence of neurological illnesses is driving the growth of the brain pacemaker market.

Medtronic Introduces Percept RC with BrainSense Technology to Advance Deep Brain Stimulation Therapy
Major companies operating in the brain pacemaker market are developing innovative products with advanced technologies, such as BrainSense technology, to enhance the precision and personalization of deep brain stimulation therapies. BrainSense technology captures and records brain signals, providing real-time data to personalize and optimize deep brain stimulation therapy. For instance, in January 2024, Medtronic, a US-based medical technology company, introduced the Percept RC deep brain stimulation (DBS) system. The Percept RC is the smallest and thinnest dual-channel neurostimulator available for DBS, featuring Medtronic's exclusive BrainSense technology. DBS therapy use a surgically implanted medical device, identical to a cardiac pacemaker, to administer electrical stimulation to precisely specified locations. BrainSense technology enables the Percept RC to capture and record brain signals, offering valuable insights that allow healthcare providers to adapt and personalize DBS therapy to meet the patient's evolving needs.

The brain pacemaker market covered in this report is segmented -
1) By Type: Single Channel, Dual Channel
2) By Application: Dystonia, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Parkinson's Disease, Other Applications
3) By Sales Channel: Channel Sales, Direct Sales
4) By End-User: Hospitals, Ambulatory Surgical Centers And Clinics, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16634&type=discount

Major companies operating in the brain pacemaker market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, Renishaw plc, Beijing PINS Medical Co. Ltd., NeuroPace Inc., SPR Therapeutics, SceneRay Co. Ltd., Nexeon MedSystems Inc., Soterix Medical Inc., BrainsGate Ltd., Functional Neuromodulation Inc., Aleva Neurotherapeutics SA, NeuroSigma Inc., NeuroOne Medical Technology, Fisher Wallace Laboratories Inc., Bioinduction Limited, Neuronetics Inc., Synchron Inc., Neuro Device Group S.A.

Contents of the report:
1. Executive Summary
2. Brain Pacemaker Market Report Structure
3. Brain Pacemaker Market Trends And Strategies
4. Brain Pacemaker Market - Macro Economic Scenario
5. Brain Pacemaker Market Size And Growth
…..
27. Brain Pacemaker Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/brain-pacemaker-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.